Nutritional abnormalities contributing to cachexia in chronic illness

International Journal of Cardiology

Volumn 85, Issue 1, 2002, Pages 23-31

  Witte, Klaus K A ^a   Clark, Andrew L ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Cachexia; Chronic heart failure; Nutritional abnormality

Indexed keywords

ADENOSINE TRIPHOSPHATE; CATECHOLAMINE; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; FREE RADICAL; GLUCOCORTICOID; GLUTAMINE; INTERLEUKIN 1BETA; INTERMEDIN; LEPTIN; NEUROPEPTIDE Y; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RETINOL; RIBOFLAVIN; SELENIUM; SEROTONIN; THIAMINE; TRACE ELEMENT; TUMOR NECROSIS FACTOR ALPHA; ZINC;

ADRENERGIC SYSTEM; ANOREXIA; ANTIOXIDANT ACTIVITY; APPETITE; CACHEXIA; CALORIC INTAKE; CYTOKINE PRODUCTION; DIETARY INTAKE; DISEASE COURSE; HEART FAILURE; HUMAN; MALABSORPTION; METABOLISM; NONHUMAN; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INTAKE; PROTEIN MALNUTRITION; REVIEW; SUPPLEMENTATION; WASTING SYNDROME;

CACHEXIA; CHRONIC DISEASE; HEART FAILURE, CONGESTIVE; HUMANS; WASTING SYNDROME;

EID: 0036345410     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00231-0     Document Type: Review

References (139)

1. The meaning and measurement of lean body mass
2. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation
3. Body weight in chronic obstructive pulmonary disease
4. Survival of diabetic patients on peritoneal dialysis or hemodialysis
5. Wasting as an independent risk factor for mortality in chronic heart failure
6. Three year mortality in heart failure patients with very low left ventricular ejection fractions
7. Cardiac cachexia is a world-wide problem
8. Cross-sectional and longitudinal evaluation of body composition in men with HIV Infection
9. Risk of death from Alzheimer's disease in a community population of older persons
10. Impact of liver cirrhosis on nutritional and immunological status
11. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease
12. Cachexia and anorexia in malignancy
13. Prevalence and haemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy
14. Effects of tumor type and burden on carcass lipid depletion in mice
15. The pathogenesis of cardiac cachexia
16. Relation of daily activity levels in patients with chronic heart failure to long-term prognosis
17. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity
18. Increased metabolic rate in patients with congestive heart failure
19. Resting energy expenditure in chronic cardiac failure
20. Energy expenditure and symptom severity in men with heart failure
21. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function
22. Catabolism in chronic heart failure
23. Edema of cardiac origin. Studies of body water and sodium, renal function, haemodynamic indexes, and plasma hormones in untreated congestive cardiac failure
24. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
25. Tumour necrosis factor and steroid metabolism in chronic heart failure: Possible relation to muscle wasting
26. Insulin resistance in chronic heart failure
27. Insulin resistance in chronic heart failure: Relation to severity and aetiology of heart failure
28. Deficient insulin-like growth factor-I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation
29. Metabolic effects of cachectin/tumour necrosis factor are modified by site of production: Cachectin/tumour necrosis factor-secreting tumour in skeletal muscle induces chronic cachexia, while implantation in brain induces predominately acute anorexia
30. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients
31. Determinants of leptin gene expression in fat depots of lean mice
32. Vagal stimulation rapidly increases leptin secretion in human stomach
33. Effects of the obese gene product on body weight regulation in ob/ob mice
34. Weight reducing effects of the plasma protein encoded by the obese gene
35. The metabolic significance of leptin in humans: Gender based differences in relation to adiposity, insulin sensitivity, and energy expenditure
36. Leptin concentrations and insulin sensitivity in normoglycaemic men
37. High-dose leptin activates human leukocytes via receptor expression on monocytes
38. Relation of leptin and insulin to adiposity-associated elevations in sympathetic activity with age in humans
39. Leptin and thermogenesis in humans
40. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia
41. The acute leptin response to GH
42. Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition
43. Influence of cortisol status on leptin secretion
44. The role of neuropeptide Y in the antiobesity action of the obese gene product
45. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: A putative hypothalamic site for energy homeostasis
46. The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lea and obese rats
47. Effect of cytokines on hypothalamic neuropeptide Y release in vitro
48. Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the alpha 1-receptor antagonist prazosin
49. An assessment of the involvement of paraventricular hypothalamic alpha 2-adrenoceptors in phenylpropanolamine anorexia
50. Evidence for the involvement of dopamine D(1) and D(2) receptors in mediating the decrease of food intake during repeated treatment with amphetamine
51. Synchronized release of dopamine and serotonin in the medial and lateral hypothalamus of rats
52. Leptin response to endogenous acute stress is independent of pituitary function
53. Acute fenfluramine administration reduced neuropeptide Y concentrations in specific hypothalamic regions of the rat: Possible implications for the anorectic effect of fenfluramine
54. CRF in the paraventricular nucleus of the hypothalamus induces dose-related behavioural profile in rats
55. Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta, LPS, and MDP
56. High fat diets elevate adipose tissue-derived tumor necrosis factor-alpha activity
57. Daily energy requirements in heart failure patients
58. Hyperleptinaemia in chronic heart failure; Relationships with insulin
59. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha
60. Expression of ob gene in adipose cells. Regulation by insulin
61. The ob gene and insulin. A relationship leading to clues to the understanding of obesity
62. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure
63. Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by alpha2-adrenoceptors
64. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
65. The role of hypothalamic noradrenergic neurons in food intake regulation
66. Central melanocortins and the regulation of weight during acute and chronic disease
67. Leptin concentrations in relation to body mass index and the tumour necrosis factor-alpha system in humans
68. Interleukins and tumor necrosis factor as inhibitors of food intake
69. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure
70. Elevated circulating levels of tumour necrosis factor in severe chronic heart failure
71. Elevated plasma levels of tumour necrosis factor in chronic heart failure with cachexia
72. Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: The potential importance of bacterial translocation
73. Leptin concentrations in relation to body mass index and the tumour necrosis factor-alpha system in humans
74. Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system
75. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease
76. Cytokines and liver diseases
77. Circulating leptin in patients with chronic obstructive pulmonary disease
78. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study
79. Uremic anorexia: A consequence of persistently high brain serotonin levels? The tryptophan/serotonin disorder hypothesis
80. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
81. Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure effects of long-term dietary supplementation
82. Nutritional status of urban homebound older adults
83. Nutritional status survey of healthy noninstitutionalized elderly: Energy and nutrient intakes from three-day diet records and nutrient supplements
84. Nutrient intakes and dietary patterns of older Americans: A national study
85. Inadequate nutrient intakes are common and are associated with low diet variety in rural, community-dwelling elderly
86. Nutritional pharmacotherapy of chronic liver disease: From support of liver failure to prevention of liver cancer
87. Nutrition and mortality in hemodialysis
88. Protein-energy malnutrition as a risk factor for increased morbidity in long-term hemodialysis patients
89. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients
90. Chronic heart failure and micronutrients
91. Micronutrients: Highlights and research challenges from the 1994-5 National Diet and Nutrition Survey of people aged 65 years and over
92. Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia
93. Nutrient intake and body weight in a large HIV cohort that includes women and minorities
94. Deficiencies of vitamins in CAPD patients: The effect of supplementation
95. Micronutrient status and immune function in tuberculosis
96. Cystic fibrosis: Nutritional status and micronutrients
97. Role of micronutrients in HIV-infected intravenous drug users
98. Racial group differences in plasma concentrations of antioxidant vitamins and carotenoids in hemodialysis patients
99. Time course of structure, function and metabolic changes due to an exogenous source of oxygen metabolites in rat heart
100. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model
101. Role of oxidative stress in transition of hypertrophy to heart failure
102. Elevated breath pentane in heart failure reduced by free radical scavenger
103. Evidence for free radical activity in chronic congestive heart failure secondary to coronary artery disease
104. Increased malondialdehyde in peripheral blood of patients with congestive heart failure
105. Increased oxidative stress in patients with congestive heart failure
106. Oxygen free radicals and congestive heart failure
107. Oxidative stress is related to exercise intolerance in patients with heart failure
108. Plasma norephinephrine as a guide to prognosis in patients with congestive heart failure
109. Myocardial catecholamines and the pathophysiology of heart failure
110. Elevated circulating levels of tumour necrosis factor in severe chronic heart failure
111. Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis
112. Supplementation with vitamins C and E suppresses leukocyte oxygen free radical production in patients with myocardial infarction
113. Decreased ubiquinone levels in tissues of rats deficient in selenium
114. Zinc status in human immunodeficiency virus infection
115. Influence of highly active antiretroviral therapy on micronutrient profiles in HIV-infected patients
116. The NAD+ precursors, nicotinic acid and nicotinamide protect cells against apoptosis induced by a multiple stress inducer, deoxycholate
117. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users
118. Effects of vitamin A supplementation during pregnancy and early lactation on body weight of South African HIV-infected women
119. Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
120. Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets
121. Role of glutamine in immunologic responses
122. Glutamine deficiency renders human monocytic cells more susceptible to specific apoptosis triggers
123. Plasma glutamine depletion and patient outcome in acute ICU admissions
124. Plasma amino acid levels in patients with chronic obstructive pulmonary disease
125. Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease
126. Outcome of critically ill patients after supplementation with glutamine
127. Glutamine supplementation in cancer patients
128. Glutamine deficiency as a cause of human immunodeficiency virus wasting
129. Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: A randomized, double-blind controlled trial
130. Fat malabsorption in elderly patients with cardiac cachexia
131. Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis
132. Effect of intracerebroventricular injection of tumor necrosis factor alpha on gut mucosal protein turnover in mice fed enterally
133. Gastrointestinal protein loss in elderly patients with cardiac cachexia
134. Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers
135. Furosemide-induced thiamine deficiency
136. Thiamine deficiency in patients with congestive cardiac failure receiving long-term furosemide therapy: A pilot study
137. Thiamine status, diuretic medications, and the management of congestive heart failure
138. Clinical relevance of thiamine status amongst hospitalised elderly patients
139. Thiamine deficiency in hospitalised elderly patients